Measurement of the Quality of Pediatric CPR
Status: | Completed |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 1 - 7 |
Updated: | 3/1/2014 |
Start Date: | October 2010 |
End Date: | December 2013 |
Contact: | Dana Niles, MS |
Email: | niles@email.chop.edu |
Phone: | 215-590-4039 |
Pediatric CPR Quality: Quantitative Measurement of Pediatric Cardiopulmonary Resuscitation (CPR) Quality During In-Hospital Cardiac Arrest
Outcomes for pediatric cardiopulmonary resuscitation (CPR) are suboptimal. CPR quality is
directly related to resuscitation outcome, yet numerous deficiencies in CPR quality have
been documented in adult studies. While similar deficiencies can be expected in pediatric
resuscitation attempts, there is little to no data evaluating the existing quality of CPR
performed during resuscitation attempts. Therefore, the objective of this study is to
quantitatively evaluate existing CPR quality using a Q-CPR compression sensor manufactured
by Philips Medical Systems with technology from Laerdal Medical.
directly related to resuscitation outcome, yet numerous deficiencies in CPR quality have
been documented in adult studies. While similar deficiencies can be expected in pediatric
resuscitation attempts, there is little to no data evaluating the existing quality of CPR
performed during resuscitation attempts. Therefore, the objective of this study is to
quantitatively evaluate existing CPR quality using a Q-CPR compression sensor manufactured
by Philips Medical Systems with technology from Laerdal Medical.
In the event of a cardiac arrest in the pediatric intensive care unit, a 24 hour paging
system will notify the Cardiac Arrest Research Team to facilitate data collection. This
system has been active as part of The Children's Hospital of Philadelphia (CHOP)
Institutional Review Board (IRB) Protocol No. 2006-6-4839, and has resulted in capture of
more than 95% of eligible events.
Cardiac arrest events requiring chest compressions in the PICU (pediatric intensive care
unit) involving children greater than or equal to 1 year of age, but less than 8 years of
age and who were previously screened, identified, and who have provided written consent are
eligible for study. CPR quality will be recorded with the modified Heartstart MRx with
Q-CPR Option, an external defibrillator with a chest compression sensor interposed between
the hands of the rescuer providing chest compressions and the sternum of the patient. The
device to be used is a regular Heartstart MRx with Quality of CPR (Q-CPR) Option cleared
under 510(k) Premarket notification - K051134, but which has been modified for this study.
In its current version, Q-CPR Option is approved for patients ≥ 8 years of age and has been
utilized in the CHOP Pediatric Intensive Care Unit (PICU) under CHOP IRB Protocol No.
2006-6-4839. This Q-CPR Option on the Heartstart MRx has been modified for this study to
accommodate children 1 year to less than 8 years of age. Since the device has been modified
for use in this study, the device is an Investigational Device during this study regulated
by the IDE regulation (CFR 21 Part 812). FDA has determined through a pre-investigational
device exemption (IDE) process (I090674) that the use of the Heartstart MRx with the
modified Q-CPR Option in a non-significant risk (NSR) device study. Two primary
modifications were done on the Q-CPR Option: 1) changing the size of the compressions sensor
footprint that interfaces with the patient's chest and 2) disabling the audiovisual Q-CPR
feedback. Specifically the contact area of the compression sensor has been reduced to
better mimic the area of the heel of a hand - the current recommended interface between the
CPR administrator and the patient's chest during usual CPR / resuscitative care.
Furthermore, no audiovisual feedback will be provided for this patient group as absolute
measurement-based CPR quality targets do not exist for this age group. The device records
CPR parameters (depth and rate of chest compressions), as well as electrocardiographic (ECG)
data, and defibrillation shock data (if used). The pad relays this information to a
recording component on the defibrillator which stores such data onto an internal data card.
Once the cardiac arrest is completed, the MRx data can be exported to an external data card
and downloaded to a secure laptop.
The investigator will use the Study Data Collection Form I in the Appendix to collect
additional information immediately after resuscitation event has concluded. The patient's
medical record will also be accessed and data will be collected as specified in the Medical
Record Data Collection Form II. In addition to medical information, data collected will
also include the post arrest chest depth in centimeters (cm) of the patient, chest
circumference (cm) and details of the mattress and bed on which the child was resuscitated.
Phase 2 procedures will be identical to those employed as per CHOP IRB Protocol No.
2006-6-4839.
system will notify the Cardiac Arrest Research Team to facilitate data collection. This
system has been active as part of The Children's Hospital of Philadelphia (CHOP)
Institutional Review Board (IRB) Protocol No. 2006-6-4839, and has resulted in capture of
more than 95% of eligible events.
Cardiac arrest events requiring chest compressions in the PICU (pediatric intensive care
unit) involving children greater than or equal to 1 year of age, but less than 8 years of
age and who were previously screened, identified, and who have provided written consent are
eligible for study. CPR quality will be recorded with the modified Heartstart MRx with
Q-CPR Option, an external defibrillator with a chest compression sensor interposed between
the hands of the rescuer providing chest compressions and the sternum of the patient. The
device to be used is a regular Heartstart MRx with Quality of CPR (Q-CPR) Option cleared
under 510(k) Premarket notification - K051134, but which has been modified for this study.
In its current version, Q-CPR Option is approved for patients ≥ 8 years of age and has been
utilized in the CHOP Pediatric Intensive Care Unit (PICU) under CHOP IRB Protocol No.
2006-6-4839. This Q-CPR Option on the Heartstart MRx has been modified for this study to
accommodate children 1 year to less than 8 years of age. Since the device has been modified
for use in this study, the device is an Investigational Device during this study regulated
by the IDE regulation (CFR 21 Part 812). FDA has determined through a pre-investigational
device exemption (IDE) process (I090674) that the use of the Heartstart MRx with the
modified Q-CPR Option in a non-significant risk (NSR) device study. Two primary
modifications were done on the Q-CPR Option: 1) changing the size of the compressions sensor
footprint that interfaces with the patient's chest and 2) disabling the audiovisual Q-CPR
feedback. Specifically the contact area of the compression sensor has been reduced to
better mimic the area of the heel of a hand - the current recommended interface between the
CPR administrator and the patient's chest during usual CPR / resuscitative care.
Furthermore, no audiovisual feedback will be provided for this patient group as absolute
measurement-based CPR quality targets do not exist for this age group. The device records
CPR parameters (depth and rate of chest compressions), as well as electrocardiographic (ECG)
data, and defibrillation shock data (if used). The pad relays this information to a
recording component on the defibrillator which stores such data onto an internal data card.
Once the cardiac arrest is completed, the MRx data can be exported to an external data card
and downloaded to a secure laptop.
The investigator will use the Study Data Collection Form I in the Appendix to collect
additional information immediately after resuscitation event has concluded. The patient's
medical record will also be accessed and data will be collected as specified in the Medical
Record Data Collection Form II. In addition to medical information, data collected will
also include the post arrest chest depth in centimeters (cm) of the patient, chest
circumference (cm) and details of the mattress and bed on which the child was resuscitated.
Phase 2 procedures will be identical to those employed as per CHOP IRB Protocol No.
2006-6-4839.
Inclusion Criteria:
Cardiac Arrest Inclusion Criteria
1. Cardiac arrests (chest compression events) occurring in the pediatric intensive care
unit
2. Arrest patient age 1 year to less than 8 years
3. Subject pre-screened by a member of the Cardiac Arrest Research Team for safe use of
the modified MRx/Quality of CPR (Q-CPR)
4. The modified MRx/Quality of CPR (Q-CPR) Compressions Sensor deployed
Clinical Staff Inclusion Criteria
5. All clinical staff who participate in enrolled resuscitation events and who provided
chest compressions
Exclusion Criteria:
Cardiac Arrest Exclusion Criteria
1. Cardiac arrests for patients classified as do not attempt resuscitation (DNAR)
2. Patient condition or size resulting in attending physician or physician fellow
designee deciding not to deploy the modified MRx/Quality of CPR (Q-CPR) chest
compression sensor (e.g., recent sternotomy)
We found this trial at
1
site
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials